scholarly journals HIV-1 subtypes and drug resistance mutations among female sex workers varied in different cities and regions of the Democratic Republic of Congo

PLoS ONE ◽  
2020 ◽  
Vol 15 (2) ◽  
pp. e0228670
Author(s):  
Eun Hee Kwon ◽  
Godefroid M. A. Musema ◽  
Jessica Boelter ◽  
Sydney Townsend ◽  
Désiré Tshala-Katumbay ◽  
...  
2020 ◽  
Vol 36 (2) ◽  
pp. 99-100 ◽  
Author(s):  
Luana Mota da Costa ◽  
Paula Cristina R. Frade ◽  
Lucinaldo da Silva Blandtt ◽  
Gláucia C. Silva-Oliveira ◽  
Luiz Fernando A. Machado ◽  
...  

2020 ◽  
Vol 36 ◽  
Author(s):  
Christian Kakisingi ◽  
Michel Muteba ◽  
Olivier Mukuku ◽  
Veronique Kyabu ◽  
Kevin Ngwej ◽  
...  

PLoS ONE ◽  
2021 ◽  
Vol 16 (4) ◽  
pp. e0248835
Author(s):  
Marina Rubio-Garrido ◽  
Gabriel Reina ◽  
Adolphe Ndarabu ◽  
Ana Rodriguez-Galet ◽  
Ana Valadés-Alcaraz ◽  
...  

Background The inadequacy of HIV viraemia and resistance monitoring in Africa leads to uncontrolled circulation of HIV strains with drug resistance mutations (DRM), compromising antiretroviral therapy (ART) effectiveness. This study describes the DRM prevalence and its therapeutic impact in HIV-infected pediatric patients from Kinshasa (Democratic Republic of Congo, DRC). Methods From 2016–2018, dried blood were collected from 71 HIV-infected children and adolescents under ART in two hospitals in Kinshasa for HIV-1 DRM pol analysis, predicted ARV-susceptibility by Stanford and phylogenetic characterization. Results HIV-1 sequences were recovered from 55 children/adolescents with 14 years of median-age. All had received nucleoside and non-nucleoside reverse transcriptase inhibitors (NRTI, NNRTI), 9.1% protease inhibitors (PI) and only one integrase inhibitor (INI). Despite the use of ART, 89.1% showed virological failure and 67.3% carried viruses with major-DRM to one (12.7%), two (47.3%), or three (5.5%) ARV-families. Most children/adolescents harbored DRM to NNRTI (73.5%) or NRTI (61.2%). Major-DRM to PI was present in 8.3% and minor-DRM to INI in 15%. Dual-class-NRTI+NNRTI resistance appeared in 53.1% of patients. Viruses presented high/intermediate resistance to nevirapine (72.9% patients), efavirenz (70.9%), emtricitabine/lamivudine (47.9%), rilpivirine (41.7%), etravirine (39.6%), doravidine (33.3%), zidovudine (22.9%), among others. Most participants were susceptible to INI and PI. Great diversity of variants was found, with a high rate (40%) of unique recombinants. Conclusion The high DRM prevalence observed among HIV-infected children and adolescents in Kinshasa could compromise the 95-95-95-UNAIDS targets in the DRC. It also reinforces the need for routine resistance monitoring for optimal rescue therapy election in this vulnerable population to control the spread of resistant HIV in the country.


2007 ◽  
Vol 34 (4) ◽  
pp. 203-208 ◽  
Author(s):  
Judith M. Vandepitte ◽  
Faustin Malele ◽  
Dieu-Mer??i Kivuvu ◽  
Samuel Edidi ◽  
J??r??mie Muwonga ◽  
...  

PLoS ONE ◽  
2017 ◽  
Vol 12 (12) ◽  
pp. e0188606 ◽  
Author(s):  
Jenny Coetzee ◽  
Gillian Hunt ◽  
Maya Jaffer ◽  
Kennedy Otwombe ◽  
Lesley Scott ◽  
...  

2020 ◽  
Vol 17 (1) ◽  
Author(s):  
Jacob Lindman ◽  
◽  
Mamadu Aliu Djalo ◽  
Ansu Biai ◽  
Fredrik Månsson ◽  
...  

2012 ◽  
Vol 84 (10) ◽  
pp. 1514-1521 ◽  
Author(s):  
Wendy Murillo ◽  
Ivette Lorenzana de Rivera ◽  
Jan Albert ◽  
María Elena Guardado ◽  
Ana Isabel Nieto ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document